The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of (68)Ga-PSMA PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of (68)Ga-PSMA PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
European journal of nuclear medicine and molecular imaging. 2017 Mar 10 [Epub ahead of print]
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Francesco Ceci, Steven Cho, Frederik Giesel, Uwe Haberkorn, Thomas A Hope, Klaus Kopka, Bernd J Krause, Felix M Mottaghy, Heiko Schöder, John Sunderland, Simon Wan, Hans-Jürgen Wester, Stefano Fanti, Ken Herrmann
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave, 200 Medical Plaza, Los Angeles, CA, USA., Department of Nuclear Medicine & Endocrinology, PET-CT Center, St. Vincent's Hospital, Linz, Austria., Institute of Nuclear Medicine, UCL/UCLH, London, UK., Nuclear Medicine Unit, University of Bologna, S. Orsola Hospital Bologna, Bologna, Italy., Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Department of Nuclear Medicine, University Hospital Heidelberg and DKFZ Heidelberg, Heidelberg, Germany., Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA., Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Department of Nuclear Medicine, University Medical Center, University of Rostock, Rostock, Germany., Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany., Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Pharmaceutical Radiochemistry, Technische Universität München, Walther-Meißner-Str.3, 85748, Garching, Germany., Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave, 200 Medical Plaza, Los Angeles, CA, USA. .